UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Friedewald-Estimated Versus Directly Measured Low-Density Lipoprotein Cholesterol and Treatment Implications

Journal of the American College of Cardiology, 2013-08, Vol.62 (8), p.732-739

2013

Volltextzugriff (PDF)

Obesity, adiposity, and dyslipidemia: A consensus statement from the National Lipid Association

Journal of clinical lipidology, 2013-07, Vol.7 (4), p.304-383

2013

Volltextzugriff (PDF)

Novel Therapies for Low-Density Lipoprotein Cholesterol Reduction

The American journal of cardiology, 2016-09, Vol.118 (6), p.19A-32A

Toth, Peter P., MD, PhD, FCCP, FAHA, FACC

2016

Volltextzugriff (PDF)

A clinician's guide to statin drug-drug interactions

Journal of clinical lipidology, 2014-05, Vol.8 (3), p.S30-S46

2014

Volltextzugriff (PDF)

Prevalence of dyslipidemia and associated risk factors in Turkish adults

Journal of clinical lipidology, 2014-03, Vol.8 (2), p.206-216

2014

Volltextzugriff (PDF)

Severe hypertriglyceridemia and factors associated with acute pancreatitis in an integrated health care system

Journal of clinical lipidology, 2016-07, Vol.10 (4), p.880-890

2016

Volltextzugriff (PDF)

Treatment of Dyslipidemia in Elderly Patients With Coronary Heart Disease

Journal of the American College of Cardiology, 2015-10, Vol.66 (17), p.1873-1875

Toth, Peter P., MD, PhD

2015

Volltextzugriff (PDF)

Non–High-Density Lipoprotein Cholesterol, Guideline Targets, and Population Percentiles for Secondary Prevention in 1.3 Million Adults

Journal of the American College of Cardiology, 2013-11, Vol.62 (21), p.1960-1965

2013

Volltextzugriff (PDF)

Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease

Journal of clinical lipidology, 2015-07, Vol.9 (4), p.576-582

2015

Volltextzugriff (PDF)

Relation of Fish Oil Supplementation to Markers of Atherothrombotic Risk in Patients With Cardiovascular Disease Not Receiving Lipid-Lowering Therapy

The American journal of cardiology, 2015-05, Vol.115 (9), p.1204-1211

2015

Volltextzugriff (PDF)

An evidence-based analysis of the National Lipid Association recommendations concerning non-HDL-C and apoB

Journal of clinical lipidology, 2016-09, Vol.10 (5), p.1248-1258

2016

Volltextzugriff (PDF)

High-Density Lipoprotein Metabolism: Potential Therapeutic Targets

The American journal of cardiology, 2007-12, Vol.100 (11), p.S32-S40

2007

Volltextzugriff (PDF)

The effects of statin treatment on adrenal and sexual function and nitric oxide levels in hypercholesterolemic male patients treated with a statin

Journal of clinical lipidology, 2016-11, Vol.10 (6), p.1452-1461

2016

Volltextzugriff (PDF)

Antisense therapy and emerging applications for the management of dyslipidemia

Journal of clinical lipidology, 2011-11, Vol.5 (6), p.441-449

Toth, Peter P., MD, PhD

2011

Volltextzugriff (PDF)

Emerging LDL therapies: Mipomersen—antisense oligonucleotide therapy in the management of hypercholesterolemia

Journal of clinical lipidology, 2013-05, Vol.7 (3), p.S6-S10

Toth, Peter P., MD, PhD, FAAFP, FICA, FNLA, FAHA, FCCP, FACC

2013

Volltextzugriff (PDF)

Screening and advanced lipid phenotyping in familial hypercholesterolemia: The Very Large Database of Lipids Study-17 (VLDL-17)

Journal of clinical lipidology, 2015-09, Vol.9 (5), p.676-683

2015

Volltextzugriff (PDF)

Epicardial Steatosis, Insulin Resistance, and Coronary Artery Disease

Heart failure clinics, 2012-10, Vol.8 (4), p.671-678

Toth, Peter P., MD, PhD, FNLA, FCCP

2012

Volltextzugriff (PDF)

Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease

Journal of clinical lipidology, 2014-01, Vol.8 (1), p.107-116

2014

Volltextzugriff (PDF)

The Risk-Benefit Paradigm vs the Causal Exposure Paradigm: LDL as a primary cause of vascular disease

Journal of clinical lipidology, 2014-11, Vol.8 (6), p.594-605

2014

Volltextzugriff (PDF)

Prevalence of lipid abnormalities in the United States: The National Health and Nutrition Examination Survey 2003–2006

Journal of clinical lipidology, 2012-07, Vol.6 (4), p.325-330

2012

Volltextzugriff (PDF)

Is HPS2-THRIVE the death knell for niacin?

Journal of clinical lipidology, 2015-05, Vol.9 (3), p.343-350

2015

Volltextzugriff (PDF)

No Changes In Average Lipid Profiles In The United States From 2003 To 2012: The National Health And Nutrition Examination Survey 2003–2012

Journal of clinical lipidology, 2016-05, Vol.10 (3), p.661-662

2016

Volltextzugriff (PDF)

Low-Density Lipoprotein Cholesterol Goal Attainment: Time-Sensitivity Analysis Using National Health And Nutrition Examination Survey Data (2003–2012)

Journal of clinical lipidology, 2016-05, Vol.10 (3), p.662-663

2016

Volltextzugriff (PDF)

High-density lipoproteins: Marker of cardiovascular risk and therapeutic target

Journal of clinical lipidology, 2010-09, Vol.4 (5), p.359-364

2010

Volltextzugriff (PDF)

1 – 25 von 77

Suche als RSS-Feed

Aktive Filter

ThemaCardiovascular

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(74)

Publikationsform

Artikel
(76)
Buchkapitel
(1)

Sprache

Englisch
(77)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(41)
Science & Technology
(41)
Humans
(38)
Pharmacology & Pharmacy
(28)
Middle Aged
(15)
Cardiovascular System & Cardiology
(13)
Cholesterol, Ldl - Blood
(13)
Male
(13)
Risk Factors
(13)
Cardiac & Cardiovascular Systems
(12)
Cholesterol
(11)
Female
(11)
Cardiovascular Disease
(10)
Adult
(9)
Triglycerides - Blood
(9)
Aged
(8)
Cardiology
(8)
Hydroxymethylglutaryl-Coa Reductase Inhibitors - Therapeutic Use
(8)
Risk Assessment
(8)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Friedewald-Estimated Versus Directly Measured Low-Density Lipoprotein Cholesterol and Treatment Implications

Obesity, adiposity, and dyslipidemia: A consensus statement from the National Lipid Association

Novel Therapies for Low-Density Lipoprotein Cholesterol Reduction

A clinician's guide to statin drug-drug interactions

Prevalence of dyslipidemia and associated risk factors in Turkish adults

Severe hypertriglyceridemia and factors associated with acute pancreatitis in an integrated health care system

Treatment of Dyslipidemia in Elderly Patients With Coronary Heart Disease

Non–High-Density Lipoprotein Cholesterol, Guideline Targets, and Population Percentiles for Secondary Prevention in 1.3 Million Adults

Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation

Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease

Relation of Fish Oil Supplementation to Markers of Atherothrombotic Risk in Patients With Cardiovascular Disease Not Receiving Lipid-Lowering Therapy

An evidence-based analysis of the National Lipid Association recommendations concerning non-HDL-C and apoB

High-Density Lipoprotein Metabolism: Potential Therapeutic Targets

The effects of statin treatment on adrenal and sexual function and nitric oxide levels in hypercholesterolemic male patients treated with a statin

Antisense therapy and emerging applications for the management of dyslipidemia

Emerging LDL therapies: Mipomersen—antisense oligonucleotide therapy in the management of hypercholesterolemia

Screening and advanced lipid phenotyping in familial hypercholesterolemia: The Very Large Database of Lipids Study-17 (VLDL-17)

Epicardial Steatosis, Insulin Resistance, and Coronary Artery Disease

Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease

The Risk-Benefit Paradigm vs the Causal Exposure Paradigm: LDL as a primary cause of vascular disease

Prevalence of lipid abnormalities in the United States: The National Health and Nutrition Examination Survey 2003–2006

Is HPS2-THRIVE the death knell for niacin?

No Changes In Average Lipid Profiles In The United States From 2003 To 2012: The National Health And Nutrition Examination Survey 2003–2012

Low-Density Lipoprotein Cholesterol Goal Attainment: Time-Sensitivity Analysis Using National Health And Nutrition Examination Survey Data (2003–2012)

High-density lipoproteins: Marker of cardiovascular risk and therapeutic target

Aktive Filter

Suchergebnisse filtern